The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

P. Jain; H. Kantarjian; F. Ravandi; D. Thomas; S. O'Brien; T. Kadia; J. Burger; G. Borthakur; N. Daver; E. Jabbour; M. Konopleva; J. Cortes; N. Pemmaraju; M. A. Kelly; M. Cardenas-Turanzas; R. Garris; S. Faderl

doi:10.1038/leu.2013.312

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

P. Jain, H. Kantarjian, F. Ravandi, D. Thomas, S. O'Brien, T. Kadia, J. Burger, G. Borthakur, N. Daver, E. Jabbour, M. Konopleva, J. Cortes, N. Pemmaraju, M. A. Kelly, M. Cardenas-Turanzas, R. Garris, S. Faderl

Research output: Contribution to journal › Letter › peer-review

51 Scopus citations

Original language	English (US)
Pages (from-to)	973-975
Number of pages	3
Journal	Leukemia
Volume	28
Issue number	4
DOIs	https://doi.org/10.1038/leu.2013.312
State	Published - Apr 2014
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/leu.2013.312

Cite this

Jain, P., Kantarjian, H., Ravandi, F., Thomas, D., O'Brien, S., Kadia, T., Burger, J., Borthakur, G., Daver, N., Jabbour, E., Konopleva, M., Cortes, J., Pemmaraju, N., Kelly, M. A., Cardenas-Turanzas, M., Garris, R., & Faderl, S. (2014). The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience. Leukemia, 28(4), 973-975. https://doi.org/10.1038/leu.2013.312

Jain, P, Kantarjian, H, Ravandi, F, Thomas, D, O'Brien, S, Kadia, T, Burger, J, Borthakur, G, Daver, N, Jabbour, E, Konopleva, M, Cortes, J, Pemmaraju, N, Kelly, MA, Cardenas-Turanzas, M, Garris, R & Faderl, S 2014, 'The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience', Leukemia, vol. 28, no. 4, pp. 973-975. https://doi.org/10.1038/leu.2013.312

@article{4585e54075fe429587e20a10c089103a,

title = "The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience",

author = "P. Jain and H. Kantarjian and F. Ravandi and D. Thomas and S. O'Brien and T. Kadia and J. Burger and G. Borthakur and N. Daver and E. Jabbour and M. Konopleva and J. Cortes and N. Pemmaraju and Kelly, {M. A.} and M. Cardenas-Turanzas and R. Garris and S. Faderl",

note = "Funding Information: This study was supported partly by GlaxoSmithKline Pharmaceuticals (to SF).",

year = "2014",

month = apr,

doi = "10.1038/leu.2013.312",

language = "English (US)",

volume = "28",

pages = "973--975",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma

T2 - MD Anderson Cancer Center experience

AU - Jain, P.

AU - Kantarjian, H.

AU - Ravandi, F.

AU - Thomas, D.

AU - O'Brien, S.

AU - Kadia, T.

AU - Burger, J.

AU - Borthakur, G.

AU - Daver, N.

AU - Jabbour, E.

AU - Konopleva, M.

AU - Cortes, J.

AU - Pemmaraju, N.

AU - Kelly, M. A.

AU - Cardenas-Turanzas, M.

AU - Garris, R.

AU - Faderl, S.

N1 - Funding Information: This study was supported partly by GlaxoSmithKline Pharmaceuticals (to SF).

PY - 2014/4

Y1 - 2014/4

UR - http://www.scopus.com/inward/record.url?scp=84898402916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898402916&partnerID=8YFLogxK

U2 - 10.1038/leu.2013.312

DO - 10.1038/leu.2013.312

M3 - Letter

C2 - 24157581

AN - SCOPUS:84898402916

SN - 0887-6924

VL - 28

SP - 973

EP - 975

JO - Leukemia

JF - Leukemia

IS - 4

ER -

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this